ACIP Votes to Approve a New Vaccine with no Data on Safety

First published at 06:41 UTC on August 27th, 2019.

VaxNot

VaxNot

subscribers

Hepaslav B is a new multiple -adjuvanted vaccine which showed an increased rate of heart attack in pre-marketing studies. But, 100% of the ACIP panel voted to approve it and only after the vote did they talk about monitoring for adverse events in ...

MORE
CategoryHealth & Medical
SensitivityNormal - Content that is suitable for ages 16 and over